Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1277 of 5804
-
New balloon could offer alternative for clogged arteries
Disease control Recruiting nowEvaluating the Safety and Efficacy of Sirolimus-coated Coronary Balloon Dilatation Catheter vs Paclitaxel-coated balloon catheter for the Treatment of De Novo Coronary Bifurcation Lesions
Phase: NA • Sponsor: BrosMed Medical Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 17:41 UTC
-
New drug combo aims to fight lung cancer after first treatment fails
Disease control Recruiting nowThis is a Phase II, multisite, open-label study consisting of two parts in participants with advanced/metastatic Non-small Cell Lung Cancer (NSCLC) which progressed after a first-line chemoimmunotherapy to evaluate the combination of pumitamig (also known as BNT327, BMS-986545 or…
Phase: PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New Alzheimer's drug VY7523 enters human safety trials
Disease control OngoingThis study is to be conducted in participants with early Alzheimer's Disease to test VY7523, a new drug being researched for treatment of Alzheimer's Disease. This study will look at how safe the drug is and how it works in the brain. It was first tested in normal, healthy partic…
Phase: PHASE1, PHASE2 • Sponsor: Voyager Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a simple blood test replace invasive tissue biopsies for cancer genetics?
Diagnosis Recruiting nowThis study will evaluate the diagnostic performance of liquid biopsy for identifying molecular abnormalities among patients managed by the Multidisciplinary Molecular Biology Meeting. The gold standard considered in this study is the solid biopsy.
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
Could a stool transplant ease gut woes in scleroderma?
Disease control Recruiting nowThe purpose of this study is to characterize the intestinal flora in subjects with systemic sclerosis-related constipation and/or significant bloating and to determine safety and trends in improvements in the diversity of colonic microbiome and patient symptoms following the admi…
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a single infusion of 'Trainer' cells let kidney patients ditch daily pills?
Disease control Recruiting nowThe only curative treatment for end-stage renal disease is through kidney transplantation. Solid organ transplants success had been made possible by the development of Immunosuppressive (IS) drugs. However, the long-term survival of transplants is still shortened by the chronic d…
Phase: PHASE1 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Home rehab program aims to ease lung fibrosis symptoms
Symptom relief Recruiting nowThe purpose of this clinical trial is to determine the impact of a home-based pulmonary rehabilitation program with health coaching on patient-reported respiratory-related quality of life and physical activity, as compared to usual care in patients with fibrotic interstitial lung…
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Can a smartphone app stop a second stroke?
Disease control Recruiting nowThe purpose of this study is to develop a digital health-based intelligent management system for the secondary prevention of ischemic stroke and to evaluate its effectiveness through a multicenter randomized controlled trial, assessing its health economic value. Participants wil…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a common diabetes pill protect new Moms' hearts?
Disease control Recruiting nowThis trial is a pilot-scale, single institution randomized, placebo-controlled trial to assess the feasibility, acceptability, and efficacy of administering dapagliflozin for cardiovascular risk reduction in the postpartum period. The target population is patients at high risk of…
Phase: PHASE4 • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Scientists hunt for cholera protection clues to speed up vaccines
Knowledge-focused Recruiting nowBackground: Vibrio cholerae causes millions of cholera cases and thousands of deaths annually. Vaccines are in short supply. There is no agreement on how to introduce new vaccines or evaluate their effectiveness, and the lack of 'correlates of protection' (CoPs) against cholera i…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Uterine scarring breakthrough? 5,000-Woman study tests new surgery and stent
Disease control Recruiting nowThis research plan aims to explore a new diagnosis and treatment management model for intrauterine adhesions and verify its efficacy and feasibility through a multicenter real-world study. Intrauterine adhesions are a common gynecological disease that may affect women's fertility…
Phase: NA • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Smarter radiation aims to spare breast cancer patients from painful side effects
Symptom relief Recruiting now* Prospective, open-label, bi-center study, assessing the clinical outcomes of adaptive breast radiotherapy with ETHOS in hypersensitive patients. * Bi-centric with ETHOS center : ICM (Institut du Cancer de Montpellier) and ISC (Institut Sainte Catherine) Avignon * 500 patients w…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Heart fix in one go: new study combines two procedures for AFib patients
Disease control Recruiting nowIn patients with non-valvular AF, at high stroke risk, and who are ineligible for long-term oral anticoagulation LAAC could be an alternative to anticoagulation and safety and efficacy has been shown in several studies and registries.8 While PVI and LAAC are both conducted in the…
Sponsor: Asklepios proresearch • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New trial aims to help people with obesity lose weight without losing muscle
Disease control OngoingThis is a prospective, pragmatic, 21 month, single-center, randomized, 2-phased, open-label, parallel-group trial comparing the use of enhanced lifestyle changes (ELC) in two different sequential anti obesity medication (AOM) therapies. The ELC consists of a medically-supervised …
Phase: PHASE4 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a common diabetes drug shield hearts from AF-Related failure?
Disease control Recruiting nowHeart failure is the most important clinical endpoint event in atrial fibrillation (AF). Patients with AF complicated by heart failure have a significantly higher risk of all-cause mortality and cardiovascular mortality compared to those without heart failure. Abnormal left atria…
Phase: PHASE2 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a simple head tilt improve stroke recovery?
Disease control Recruiting nowThe DOWN-SUITE study is multicenter, randomised, controlled, open-label clinical trial with blinded outcome assessment comparing collateral status in patients with acute ischemic stroke treated with an in-hospital application of head down tilt -10° to -15° (HDT15) versus usual po…
Phase: PHASE2 • Sponsor: University of Milano Bicocca • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Poking skin to bring back color: which needle works best for vitiligo?
Disease control Recruiting nowThis randomized controlled trial aims to compare the efficacy of needling versus microneedling, both followed by narrowband UVB therapy, in achieving repigmentation in patients with localized stable non-segmental vitiligo.
Phase: PHASE4 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:18 UTC
-
New drug hopes to ease breathing and heart strain in lung disease patients
Disease control Recruiting nowThe goal of this clinical trial is to see if mirivadelgat will work in patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD). It will also learn about the safety of mirivadelgat. The main question it aims to answer is if mirivadelgat will improve…
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could pepcid and a skin lotion finally stop burn scar itching?
Symptom relief Recruiting nowThe purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.
Phase: PHASE3 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can a One-Two punch tame overgrown wound tissue?
Disease control TerminatedThis randomized controlled trial aims to compare the efficacy of silver nitrate, triamcinolone, and a successive use of both treatments in managing hypergranulation tissue in traumatic wounds. Conducted over a four-year period at UPMC Mercy, the study will involve patients presen…
Phase: PHASE2, PHASE3 • Sponsor: Francesco Egro • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC